Loading…
Shree Ganesh Biotech India (BSE 539470)₹0.4600+2.22%Biotechnology
At the end of the Jun 2026 quarter, Shree Ganesh Biotech India's shareholders were: FIIs 1.41%, public 98.59%. 0.00% of promoter shares were pledged. It had 1,81,711 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FIIs | 2.15% | 2.15% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% |
| Public | 97.85% | 97.85% | 98.59% | 98.59% | 98.59% | 98.59% | 98.59% | 98.59% | 98.59% | 98.59% | 98.59% | 98.59% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 78,091 | 1,39,872 | 1,76,711 | 1,81,187 | 1,85,324 | 1,92,028 | 1,95,423 | 1,92,223 | 1,89,364 | 1,86,137 | 1,83,647 | 1,81,711 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| New Era Fund Limited | FII | 1.43% | 0.00 |
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 1.41% (unchanged at 1.41% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
No. The Jun 2026 filing shows no pledged promoter shares.
Shree Ganesh Biotech India had 1,81,711 shareholders at the end of the Jun 2026 quarter, against 1,92,223 a year earlier.
New Era Fund Limited (FII) held 1.43% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.